Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02989038 · ClinicalTrials.gov registry record · NA

Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers

A NA study of Nicotine Dependence, sponsored by Duke University.

Completed
Registry status
NA
Development phase
182
Enrollment target
1
Study location

NCT02989038 is a NA study of Nicotine Dependence that has completed, run by Duke University. The registered enrollment target is 182 participants, roughly in line with the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02989038, a NA study of Nicotine Dependence, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
182 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.

Conditions Studied

Interventions

  • OTHER Very Low Nicotine Content Cigarettes
  • OTHER Intermediate Nicotine Content Cigarettes
  • OTHER Normal Nicotine Content Cigarettes

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2017-01
Est. Completion 2019-12-17
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02989038

The ClinicalTrials.gov registry entry for NCT02989038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Very Low Nicotine Content Cigarettes is the first listed.

NCT02989038 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02989038 about?

NCT02989038 is a clinical study titled "Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers". The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.

What is the current status of trial NCT02989038?

This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2017-01. Estimated completion is 2019-12-17.

What conditions does trial NCT02989038 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT02989038?

The interventions under investigation include: Very Low Nicotine Content Cigarettes (OTHER), Intermediate Nicotine Content Cigarettes (OTHER), Normal Nicotine Content Cigarettes (OTHER).

Who is sponsoring clinical trial NCT02989038?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02989038 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.